TY - JOUR
T1 - Evolving concepts in NAD+ metabolism
AU - Chini, Claudia C.S.
AU - Zeidler, Julianna D.
AU - Kashyap, Sonu
AU - Warner, Gina
AU - Chini, Eduardo Nunes
N1 - Funding Information:
The work in E.N.C.’s laboratory is supported in part by grants from the Helen Diller Family Foundation , Ted Nash Long Life Foundation , and the Glenn Foundation for Medical Research via the Paul F. Glenn Laboratories for the Biology of Aging at the Mayo Clinic (to E.N.C.); sponsored research funding from Calico Life Sciences ; the Mayo and Noaber Foundations ; and NIH National Institute on Aging (NIA) grants AG-26094 , AG58812 , and CA233790 (to E.N.C.).
Funding Information:
The work in E.N.C.?s laboratory is supported in part by grants from the Helen Diller Family Foundation, Ted Nash Long Life Foundation, and the Glenn Foundation for Medical Research via the Paul F. Glenn Laboratories for the Biology of Aging at the Mayo Clinic (to E.N.C.); sponsored research funding from Calico Life Sciences; the Mayo and Noaber Foundations; and NIH National Institute on Aging (NIA) grants AG-26094, AG58812, and CA233790 (to E.N.C.). All authors contributed to the writing of the manuscript and preparation of figures. E.N.C. holds a patent on the use of CD38 inhibitors for metabolic diseases that is licensed by Elysium health. E.N.C. is a consultant for TeneoBio, Calico, Mitobridge, and Cytokinetics. E.N.C. is on the advisory board of Eolo Pharma. E.N.C. own stocks in TeneoBio. Research in the E.N.C. laboratory has been conducted in compliance with Mayo Clinic conflict of interest policies.
Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2021/6/1
Y1 - 2021/6/1
N2 - NAD(H) and NADP(H) have traditionally been viewed as co-factors (or co-enzymes) involved in a myriad of oxidation-reduction reactions including the electron transport in the mitochondria. However, NAD pathway metabolites have many other important functions, including roles in signaling pathways, post-translational modifications, epigenetic changes, and regulation of RNA stability and function via NAD-capping of RNA. Non-oxidative reactions ultimately lead to the net catabolism of these nucleotides, indicating that NAD metabolism is an extremely dynamic process. In fact, recent studies have clearly demonstrated that NAD has a half-life in the order of minutes in some tissues. Several evolving concepts on the metabolism, transport, and roles of these NAD pathway metabolites in disease states such as cancer, neurodegeneration, and aging have emerged in just the last few years. In this perspective, we discuss key recent discoveries and changing concepts in NAD metabolism and biology that are reshaping the field. In addition, we will pose some open questions in NAD biology, including why NAD metabolism is so fast and dynamic in some tissues, how NAD and its precursors are transported to cells and organelles, and how NAD metabolism is integrated with inflammation and senescence. Resolving these questions will lead to significant advancements in the field.
AB - NAD(H) and NADP(H) have traditionally been viewed as co-factors (or co-enzymes) involved in a myriad of oxidation-reduction reactions including the electron transport in the mitochondria. However, NAD pathway metabolites have many other important functions, including roles in signaling pathways, post-translational modifications, epigenetic changes, and regulation of RNA stability and function via NAD-capping of RNA. Non-oxidative reactions ultimately lead to the net catabolism of these nucleotides, indicating that NAD metabolism is an extremely dynamic process. In fact, recent studies have clearly demonstrated that NAD has a half-life in the order of minutes in some tissues. Several evolving concepts on the metabolism, transport, and roles of these NAD pathway metabolites in disease states such as cancer, neurodegeneration, and aging have emerged in just the last few years. In this perspective, we discuss key recent discoveries and changing concepts in NAD metabolism and biology that are reshaping the field. In addition, we will pose some open questions in NAD biology, including why NAD metabolism is so fast and dynamic in some tissues, how NAD and its precursors are transported to cells and organelles, and how NAD metabolism is integrated with inflammation and senescence. Resolving these questions will lead to significant advancements in the field.
KW - NAD
KW - NAD pathway metabolites
KW - aging
KW - disease
KW - humans
KW - mitochondria
KW - transport
KW - vitamin B3
UR - http://www.scopus.com/inward/record.url?scp=85106650144&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85106650144&partnerID=8YFLogxK
U2 - 10.1016/j.cmet.2021.04.003
DO - 10.1016/j.cmet.2021.04.003
M3 - Review article
C2 - 33930322
AN - SCOPUS:85106650144
SN - 1550-4131
VL - 33
SP - 1076
EP - 1087
JO - Cell Metabolism
JF - Cell Metabolism
IS - 6
ER -